Factors associated with medication adherence among children with rheumatic diseases

Roongroj Manatpreeprem1, Butsabong Lerkvaleekul1, Soamarat Vilaiyuk1

  • 1Rheumatology Division, Pediatric Department, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Insights

Poor medication adherence affects one-fourth of pediatric rheumatic disease patients. Key factors include forgetfulness and lack of awareness regarding treatment importance, impacting health outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Adherence Research
  • Chronic Disease Management

Background:

  • Medication non-adherence significantly worsens health outcomes in pediatric rheumatic diseases.
  • The Pediatric Rheumatology Adherence Questionnaire (PRAQ) is a validated tool for assessing adherence.
  • Understanding factors associated with poor adherence is crucial for improving patient care.

Purpose of the Study:

  • To identify factors associated with poor medication adherence in children with rheumatic diseases.
  • To validate the Thai version of the PRAQ in this patient population.
  • To determine the prevalence of poor medication adherence in pediatric rheumatology patients.

Main Methods:

  • Cross-sectional study involving pediatric rheumatology patients and their caregivers.
  • Medication adherence assessed using the pill count method (adherence <80% defined as poor).
  • Thai version of the PRAQ administered; additional interviews conducted to identify adherence barriers.

Main Results:

  • Poor adherence was observed in approximately 25% of patients.
  • Enthesitis-related arthritis (ERA) and polyarticular juvenile idiopathic arthritis (JIA) were associated with higher rates of non-adherence.
  • Key predictors of poor adherence included longer disease duration (≥5 years), active disease, high PRAQ scores, forgetfulness, and lack of awareness regarding medication importance.

Conclusions:

  • One-fourth of children with rheumatic diseases exhibit poor medication adherence.
  • Specific diagnoses (ERA, polyarticular JIA), disease characteristics (longer duration, active disease), and higher PRAQ scores are linked to non-adherence.
  • Forgetfulness and lack of understanding about treatment necessity are primary barriers to consistent medication use.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
24
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
75
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
87
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38